Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Switching from infliximab to Ustekinumab improved both hair loss and Crohn's symptoms in the patient.

New cytokine-targeted therapies show promise for treating alopecia areata.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Psoriasis treatment may affect body hair growth, with a complex relationship between skin and hair growth mechanisms.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Minoxidil is compatible with some excipients but not with others, affecting formulation choices.

A new growth medium doubles Malassezia restricta yield by using artificial sebum.

Finasteride is stable except in high pH, and lactose and magnesium stearate should be replaced in formulations.

KFSD is a rare condition causing scarring hair loss, with no effective treatment known at the time of the report.

CTHRC1 helps hair grow back, and plantar dermis mixture boosts it.

The cream with turmeric and ginger extracts can potentially reduce underarm hair growth effectively.

Keratosis Pilaris Atrophicans causes skin scarring and might be treated with a new synthetic retinoid.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Skin conditions can signal heart issues, highlighting the need for integrated care.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.